SIGYN THERAPY Trademark

Trademark Overview


On Friday, March 8, 2024, a trademark application was filed for SIGYN THERAPY with the United States Patent and Trademark Office. The USPTO has given the SIGYN THERAPY trademark a serial number of 98440211. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, September 23, 2024. This trademark is owned by Sigyn Therapeutics, Inc.. The SIGYN THERAPY trademark is filed in the Medical Instrument Products category with the following description:

medical devices, namely extracorporeal therapeutic devices

General Information


Serial Number98440211
Word MarkSIGYN THERAPY
Filing DateFriday, March 8, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, September 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesmedical devices, namely extracorporeal therapeutic devices

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, March 8, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSigyn Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92106

Trademark Events


Event DateEvent Description
Friday, March 8, 2024NEW APPLICATION ENTERED
Monday, July 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 20, 2024ASSIGNED TO EXAMINER
Tuesday, December 17, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, December 17, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, September 23, 2024NON-FINAL ACTION E-MAILED
Monday, September 23, 2024NON-FINAL ACTION WRITTEN